Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective

Andy Pike(AstraZeneca (United Kingdom)), Beth Williamson(AstraZeneca (United Kingdom)), Stephanie Harlfinger(AstraZeneca (United Kingdom)), Scott Martin(AstraZeneca (United Kingdom)), Dermot F. McGinnity(AstraZeneca (United Kingdom))
Drug Discovery Today
July 18, 2020
Cited by 219

Abstract


Related Papers

No related papers found

Powered by citation graph analysis